Starzl T E, Porter K A, Halgrimson C G, Husberg B S, Penn I, Putnam C W
Ann Surg. 1974 Oct;180(4):606-16. doi: 10.1097/00000658-197410000-00026.
Sixty-four consecutive patients underwent renal homotransplantation 10 1/6 to 11(1/2) years ago, 46 from related and 18 from nonrelated living donors. Thirty-six of these recipients were alive when this series was presented to the American Surgical Assocation in 1965. Now, nine years later, 26 (72%) of the 36 still survive, in 22 instances with function of their original grafts. The 10 who died in the interim tended to have subnormal renal function or graft failure. However, the actual causes of death included 2 or more examples each of myocardial infarction, hepatitis, or other systemic infections. The prognosis for achieving a one decade survival was not obviously related to HL-A tissue match. The best results were with related kidneys, within which subgroup 24 (52%) of the original recipients are still alive. However, there was no particular category of consanguineous donor that had a marked superiority. Only 2 of 18 nonrelated recipients are still alive. All 36 patients who were alive in 1965 had a biopsy of their renal homograft. Kidneys that were destined to function for a decade tended to have relatively minor histopathologic abnormalities. If serious glomerular lesions were found, the outlook for long graft survival was grave. Vascular lesions had a somewhat less serious import. Mononuclear cell infiltration, tubular atrophy, and interstitial fibrosis proved prognostically to be the least significant. Long-term followup of these early cases has shown the durability of chronic renal homografts, particularly if these are from related donors, and has demonstrated the very high degree of rehabilitation that could be achieved even in the early days of renal homotransplantation.
64例患者于10又1/6至11又1/2年前接受了同种肾移植,其中46例供者为亲属,18例供者为非亲属活体。1965年向美国外科协会报告该系列病例时,这些受者中有36例存活。现在,9年后,这36例中的26例(72%)仍然存活,其中22例其原移植肾仍有功能。在此期间死亡的10例患者往往存在肾功能不全或移植肾失功。然而,实际死亡原因包括心肌梗死、肝炎或其他全身感染各2例或更多。实现10年存活的预后与HL - A组织配型无明显相关性。亲属供肾的效果最佳,在该亚组中原受者有24例(52%)仍然存活。然而,没有哪一类有血缘关系的供者具有明显优势。18例非亲属受者中只有2例仍然存活。1965年存活的所有36例患者均对其同种移植肾进行了活检。注定能有10年功能的肾脏往往组织病理学异常相对较轻。如果发现严重的肾小球病变,移植肾长期存活的前景则不佳。血管病变的影响稍小。单核细胞浸润、肾小管萎缩和间质纤维化在预后方面证明意义最小。对这些早期病例的长期随访显示了慢性同种移植肾的耐久性,特别是如果这些移植肾来自亲属供者,并且证明即使在肾同种移植的早期也能实现很高程度的康复。